Seeking Alpha
25 Jul 2026, 04:30 UTC · 1h ago
U.S. IPO Weekly Recap: CRISPR Biotech Pops 44% As More Names Join The IPO Pipeline
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Seeking Alpha
25 Jul 2026, 04:30 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
Scribe Therapeutics (SCTX) successfully priced its IPO at the high end of its range to raise $129 million. — Pricing at the high end indicates strong institutional demand for the specific asset and the biotech sector.
+0.40Two sizable IPOs and one direct listing are scheduled for the coming week. — An active IPO pipeline suggests improving risk appetite for new public offerings.
+0.20Five lock-up periods are set to expire in the coming week. — Lock-up expirations typically increase sell-side pressure and volatility for the affected stocks.
-0.20Which stocks this story touches
Continue reading
6 related stories
Search tags
The company upsized and priced its IPO at the high end of the range, raising $129 million.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Seeking Alpha
12h ago
